Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

9,003

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Flublok Quadrivalent Influenza Vaccine

Intramuscular injection of vaccine

BIOLOGICAL

Inactivated Influenza Vaccine

Intramuscular injection of vaccine

Trial Locations (38)

13760

Regional Clinical Research, Inc., Endwell

14609

Rochester Clinical Research, Rochester

23507

Clinical Research Associates of Tidewater, Norfolk

27612

Wake Research, Raleigh

31406

Meridian Research, Savannah

32127

Progressive Medical Research, Port Orange

32205

Westside Center for Clinical Research, Jacksonville

32216

Jacksonville Center for Clinical Research, Jacksonville

32720

Avail Clinical Research, DeLand

33134

Clinical Research of South Florida, Coral Gables

36608

Coastal Clinical Research, Mobile

37203

Clinical Research Associates, Nashville

40509

Central Kentucky Research Associates, Lexington

44122

Rapid Medical Research, Inc., Cleveland

57049

Meridian Research, Dakota Dunes

64114

Center for Pharmaceutical Research, Kansas City

67207

Heartland Research Associates, LLC, Wichita

68005

Meridian Research, Bellevue

68164

Meridian Clinical Research, Omaha

68701

Meridian Research, Norfolk

70006

Benchmarch Research - New Orleans, Metairie

72205

Baptist Health Center for Clinical Research, Little Rock

73069

Lynn Institute of Norman, Norman

73112

Lynn Health Science Institute, Oklahoma City

76135

Benchmark Research - Fort Worth, Fort Worth

76904

Benchmark Research - San Angelo, San Angelo

78705

Benchmark Reseach, Austin

80907

Lynn Institute of the Rockies, Colorado Springs

83642

ACR - Boise, Meridian

84124

Jean Brown Research, Salt Lake City

85283

Clinical Research Consortium Arizona, Tempe

89119

Clinical Research Consortium-Nevada, Las Vegas

94102

Benchmark Research - San Francisco, San Francisco

95816

Benchmark Research - Sacramento, Sacramento

96001

Northern California Clinical Research Center, Redding

06460

Clinical Research Consulting, Milford

01844

ActivMed Practices & Research, Methuen

03801

ActivMed Practices & Research, Newington

All Listed Sponsors
lead

Protein Sciences Corporation

INDUSTRY

NCT02285998 - Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age | Biotech Hunter | Biotech Hunter